Zobrazeno 1 - 10
of 33
pro vyhledávání: '"P M, Dowd"'
Autor:
J. C. R. Bowling, P. M. Dowd
Publikováno v:
The Lancet. 361:2078-2080
Autor:
P. M. Dowd
Publikováno v:
Rook's Textbook of Dermatology, Seventh Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2997318dfe369b91b452a5daee417249
https://doi.org/10.1002/9780470750520.ch23
https://doi.org/10.1002/9780470750520.ch23
Publikováno v:
British Journal of Dermatology. 138:480-482
This study was undertaken to ascertain the histopathology and aetiology of cutaneous nodules observed in Parkinson's patients treated with continuous subcutaneous apomorphine. Ten patients were recruited, answered questionnaires, and underwent skin b
Publikováno v:
Clinical and Experimental Dermatology. 16:11-13
Summary During an open prospective study of the synthetic retinoid isotretinoin in ten patients with systemic sclerosis, one patient developed an eosinophilic pleural effusion and two patients were noticed to have asymptomatic deterioration in pulmon
Publikováno v:
Hospital medicine (London, England : 1998). 59(5)
Autor:
J, Berth-Jones, C A, Henderson, C S, Munro, S, Rogers, R J, Chalmers, M J, Boffa, P G, Norris, P S, Friedmann, R A, Graham-Brown, P M, Dowd, R, Marks, M J, Sumner
Publikováno v:
The British journal of dermatology. 136(4)
A 1 year, prospective multicentre study was performed to investigate the efficacy and safety of intermittent treatment with cyclosporin in psoriasis vulgaris. Subjects received cyclosporin (Neoral) 5 mg/kg per day until achieving 90% reduction in are
Publikováno v:
The British journal of dermatology. 134(3)
It has been argued that the digital cutaneous microvasculature is the site of the anomaly which causes Raynaud's phenomenon (RP). Both endothelin-1 (ET-1), a potent vasoconstrictor peptide present in the digital cutaneous microvasculature, and calcit
Autor:
T A, Leslie, P M, Dowd
Publikováno v:
British journal of hospital medicine. 50(7)
Autor:
P, Goldsmith, P M, Dowd
Publikováno v:
Dermatologic clinics. 11(1)
The new H1 antihistamines are a major therapeutic advancement in the treatment of allergic disorders such as urticaria and allergic rhinitis. Their efficacy combined with greatly reduced sedating and anticholinergic side effects makes the new class o
Publikováno v:
BMJ. 307:556-557